A collection of news and information related to Arena Pharmaceuticals, Inc. published by this site and its partners.
Displaying items 1-12 of 14 » View latimes.com items only1 2 Next >
The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...
Tags: Obesity, Cancer, Heart Disease, Diabetes, High Blood Pressure
The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...
Booster ShotsAbout this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
CNNNEW YORK -- Some people who suffer from chronic weight issues may soon get some help from a pill. The U.S. Food and Drug Administration Wednesday approved Belviq, or lorcaserin hydrochloride, to be combined with a reduced-calorie diet and...
SAN DIEGO -- The U.S. Food and Drug Administration Wednesday approved a new diet drug from San Diego's Arena Pharmaceuticals. It's the first diet drug approved in more than a decade. Belviq, or lorcaserin hydrochloride is to be combined with a reduced-...
Tribune NewspapersThere has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...
AP Business WriterWASHINGTON (AP) — Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade. The drug's maker, Vivus Inc., said...
Los Angeles Times Staff WriterThis is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...
AP Business WriterWASHINGTON (AP) — Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss...
Vivus Inc.'s experimental drug Qnexa was effective in cutting weight, the Food and Drug Administration said Tuesday, while acknowledging lingering concerns over the drug's nervous system and psychiatric side effects. Still, shares of Vivus jumped as...
Tags: Health, Obesity, Vivus Inc., Weight Loss, Drugs and Medicines
The Associated PressAn experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found. Arena Pharmaceuticals' lorcaserin is one of three drugs that...
Jun 27, 2012 |Story| Los Angeles Times
Oct 25, 2010 |Story| Los Angeles Times
Oct 28, 2009 | Los Angeles Times
Jun 28, 2012 |Story| KTLA-LTV
Jun 27, 2012 |Story| CNN
Sep 7, 2011 |Story| Reuters
Sep 15, 2010 |Story| Chicago Tribune
Oct 29, 2010 |Story| Associated Press
Sep 17, 2010 |Story| Los Angeles Times
Jul 12, 2010 |Story| Associated Press
Jul 13, 2010 |Story| Associated Press
Jul 14, 2010 |Story| Associated Press